{
  "ticker": "JNJ",
  "target_date": "2025-04-16",
  "actual_date": "2025-04-16",
  "collected_at": "2025-12-08T11:38:55.481270",
  "price": {
    "open": 151.96,
    "high": 152.22,
    "low": 148.9,
    "close": 150.53404235839844,
    "volume": 7986900,
    "change_1d_pct": 0.19,
    "change_7d_pct": 2.18,
    "change_30d_pct": -6.79
  },
  "technicals": {
    "rsi_14": 38.93,
    "sma_20": 153.6,
    "sma_50": 155.91,
    "macd": -2.332,
    "macd_signal": -1.988,
    "macd_histogram": -0.343,
    "bb_upper": 164.67,
    "bb_lower": 142.53,
    "price_vs_sma20_pct": -2.0,
    "price_vs_sma50_pct": -3.45,
    "volume_ratio": 0.67
  },
  "fundamentals": {
    "market_cap": 489231450112,
    "pe_ratio": 19.600386,
    "forward_pe": 19.156603,
    "price_to_book": 6.163232,
    "price_to_sales": 5.309135,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.29,
    "pct_from_52w_low": 44.34
  },
  "macro": {
    "spy": {
      "price": 522.66,
      "change_1d_pct": -2.22,
      "change_7d_pct": 5.88
    },
    "vix": {
      "level": 32.64,
      "signal": "HIGH_FEAR"
    },
    "treasury_10y": {
      "yield_pct": 4.28
    },
    "dollar_index": {
      "level": 99.38
    },
    "gold": {
      "price": 3326.6
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ",
      "source": "Yahoo",
      "datetime": 1744842900,
      "summary": "Johnson & Johnson (JNJ) and Albertsons Companies' (ACI) stock have provided a pleasant hedge against market volatility and were able to exceed their quarterly expectations on Wednesday.",
      "url": "https://finnhub.io/api/news?id=82f5bb5b715e9cb6ce540010a1caf6ad08db270f38a487ec8c02c0cafe6a7251"
    },
    {
      "headline": "Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference",
      "source": "Finnhub",
      "datetime": 1744820943,
      "summary": "Johnson & Johnson will participate in the 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20th. Management will participate in a Fireside Chat at 1:35 p.m. Eastern Time.This...",
      "url": "https://finnhub.io/api/news?id=a263e0718044d7e472b5e0d130f06149cd1688a74947f00af42bfd5c06cb7802"
    },
    {
      "headline": "J&J\u2019s electrophysiology sales dip amid slow Varipulse start",
      "source": "Yahoo",
      "datetime": 1744820880,
      "summary": "Johnson & Johnson\u2019s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston Scientific in the red-hot pulsed field ablation market.",
      "url": "https://finnhub.io/api/news?id=dce702f53e1d060a764e9186eef1c83963ca5749aba150e64758a6a836ec1d04"
    },
    {
      "headline": "Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz",
      "source": "Yahoo",
      "datetime": 1744819176,
      "summary": "The major averages were fractionally higher near noon, adding slightly to yesterday\u2019s gains as investors reacted to fresh headlines on U.S.-China trade tensions and a new round of corporate earnings. Markets are attempting to stabilize after a rocky stretch, but much of the tone is being shaped by P",
      "url": "https://finnhub.io/api/news?id=7bb7c49fe10931cfb1daba12fcbafbacfdb97dc9401770b00dfc0a0d76a8bd05"
    },
    {
      "headline": "Needham upgrades Boston Scientific on easing competition, growth opportunities",
      "source": "Yahoo",
      "datetime": 1744817076,
      "summary": "Investing.com -- Needham upgraded Boston Scientific Corp (NYSE:BSX) to \u201cBuy\u201d, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was earlier feared, and citing near- and long-term upside drivers in the company\u2019s pipeline and recent acquisitions.",
      "url": "https://finnhub.io/api/news?id=aafbd19806444be64c9aa8185e11bb960f26326e2908b8df4a92696f135158e5"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-04-15",
      "description": "jnj-20250415.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000110/jnj-20250415.htm"
    },
    {
      "form": "8-K",
      "date": "2025-04-03",
      "description": "jnj-20250331.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000106/jnj-20250331.htm"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742429234.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000103/xslF345X05/wk-form4_1742429234.xml"
    },
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297319.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000095/xslF345X05/wk-form4_1741297319.xml"
    },
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297124.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000093/xslF345X05/wk-form4_1741297124.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}